Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain
RecruitingNCT07639060
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To prospectively describe patient-centered and health utilization outcomes through 12 months after cryoneurolysis performed as routine clinical care for chronic pain at Yale.
Study details
- Official title
- Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain
- Conditions
- Chronic Pain
- Peripheral Neuropathy
- Occipital Neuralgia
- Chronic Hip Pain
- Hip Osteoarthritis
- Knee Osteoarthritis
- Spasticity
- Chronic Low Back Pain
- Lumbar Spondylosis
- Cervical Spondylosis
- Shoulder Arthritis
- Causalgia
- Chronic Pain Syndrome
- Chronic Neck Pain
- Sponsor
- Yale University
- Start date
- 2026-06-20
- Primary completion
- 2028-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of chronic pain (generally pain duration of at least 3-6 months) localized to an anatomical region appropriate for cryoneurolysis as determined by the treating physician. * Planned cryoneurolysis procedure as part of standard clinical care. * Ability to provide written informed consent. * Ability and willingness to complete baseline and follow-up questionnaires. Exclusion Criteria: * Cryoneurolysis performed as part of a separate investigational trial in which data sharing is not permitted. * Active infection or other clinical contraindication to the procedure as determined by the treating clinician. * Life expectancy of less than 12 months in the judgment of the treating clinician. * Any condition that, in the investigator's opinion, would interfere with study participation or completion of follow-up, such as severe psychiatric instability or active substance use that precludes reliable follow-up
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07639060